サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/01/25 | 4,250 | 4,460 | 4,190 | 4,455 | +230 | +5.4% | 803,300 |
| 2018/01/24 | 4,190 | 4,305 | 4,135 | 4,225 | -5 | -0.1% | 633,200 |
| 2018/01/23 | 4,165 | 4,365 | 4,140 | 4,230 | +120 | +2.9% | 975,200 |
| 2018/01/22 | 4,005 | 4,125 | 3,940 | 4,110 | +215 | +5.5% | 639,400 |
| 2018/01/19 | 3,930 | 4,145 | 3,825 | 3,895 | -55 | -1.4% | 958,400 |
| 2018/01/18 | 3,775 | 4,195 | 3,745 | 3,950 | +165 | +4.4% | 1,211,600 |
| 2018/01/17 | 3,560 | 3,785 | 3,485 | 3,785 | +215 | +6% | 619,600 |
| 2018/01/16 | 3,605 | 3,680 | 3,475 | 3,570 | -45 | -1.2% | 632,300 |
| 2018/01/15 | 3,365 | 3,635 | 3,260 | 3,615 | +265 | +7.9% | 755,300 |
| 2018/01/12 | 3,400 | 3,415 | 3,325 | 3,350 | -25 | -0.7% | 249,600 |
| 2018/01/11 | 3,295 | 3,400 | 3,270 | 3,375 | +80 | +2.4% | 421,400 |
| 2018/01/10 | 3,205 | 3,325 | 3,170 | 3,295 | +80 | +2.5% | 358,600 |
| 2018/01/09 | 3,065 | 3,230 | 3,065 | 3,215 | +100 | +3.2% | 418,900 |
| 2018/01/05 | 3,150 | 3,160 | 3,060 | 3,115 | -70 | -2.2% | 367,900 |
| 2018/01/04 | 3,290 | 3,290 | 3,160 | 3,185 | -40 | -1.2% | 446,700 |
| 2017/12/29 | 3,200 | 3,295 | 3,180 | 3,225 | +10 | +0.3% | 254,800 |
| 2017/12/28 | 3,320 | 3,430 | 3,195 | 3,215 | -85 | -2.6% | 648,300 |
| 2017/12/27 | 3,190 | 3,305 | 3,165 | 3,300 | +175 | +5.6% | 574,600 |
| 2017/12/26 | 3,125 | 3,150 | 3,075 | 3,125 | +50 | +1.6% | 247,700 |
| 2017/12/25 | 3,190 | 3,190 | 3,050 | 3,075 | -55 | -1.8% | 311,100 |
| 2017/12/22 | 3,080 | 3,195 | 3,030 | 3,130 | +35 | +1.1% | 501,800 |
| 2017/12/21 | 3,085 | 3,145 | 3,040 | 3,095 | -45 | -1.4% | 246,300 |
| 2017/12/20 | 3,105 | 3,235 | 3,050 | 3,140 | +50 | +1.6% | 296,300 |
| 2017/12/19 | 3,150 | 3,210 | 3,000 | 3,090 | -55 | -1.7% | 489,500 |
| 2017/12/18 | 3,330 | 3,340 | 3,065 | 3,145 | -170 | -5.1% | 713,100 |
| 2017/12/15 | 3,365 | 3,440 | 3,230 | 3,315 | -45 | -1.3% | 780,900 |
| 2017/12/14 | 3,220 | 3,430 | 3,040 | 3,360 | +245 | +7.9% | 1,425,800 |
| 2017/12/13 | 3,050 | 3,300 | 3,040 | 3,115 | +65 | +2.1% | 886,100 |
| 2017/12/12 | 3,010 | 3,130 | 2,996 | 3,050 | +20 | +0.7% | 310,300 |
| 2017/12/11 | 3,070 | 3,085 | 2,994 | 3,030 | ±0 | ±0% | 239,800 |
| 2017/12/08 | 2,985 | 3,040 | 2,910 | 3,030 | -20 | -0.7% | 588,900 |
| 2017/12/07 | 3,140 | 3,190 | 2,984 | 3,050 | +35 | +1.2% | 551,300 |
| 2017/12/06 | 3,000 | 3,170 | 2,898 | 3,015 | +127 | +4.4% | 1,108,400 |
| 2017/12/05 | 3,015 | 3,040 | 2,873 | 2,888 | -167 | -5.5% | 875,500 |
| 2017/12/04 | 2,875 | 3,220 | 2,865 | 3,055 | +252 | +9% | 1,307,000 |
| 2017/12/01 | 2,810 | 2,853 | 2,768 | 2,803 | -3 | -0.1% | 357,100 |
| 2017/11/30 | 2,810 | 2,870 | 2,754 | 2,806 | +1 | ±0% | 824,200 |
| 2017/11/29 | 2,610 | 2,823 | 2,610 | 2,805 | +196 | +7.5% | 1,261,200 |
| 2017/11/28 | 2,578 | 2,648 | 2,512 | 2,609 | +25 | +1% | 356,500 |
| 2017/11/27 | 2,533 | 2,688 | 2,530 | 2,584 | +51 | +2% | 767,500 |
| 2017/11/24 | 2,782 | 2,812 | 2,503 | 2,533 | -232 | -8.4% | 1,368,800 |
| 2017/11/22 | 2,664 | 2,794 | 2,657 | 2,765 | +126 | +4.8% | 883,500 |
| 2017/11/21 | 2,511 | 2,646 | 2,485 | 2,639 | +106 | +4.2% | 948,800 |
| 2017/11/20 | 2,382 | 2,570 | 2,371 | 2,533 | +145 | +6.1% | 1,282,600 |
| 2017/11/17 | 2,241 | 2,419 | 2,220 | 2,388 | +177 | +8% | 1,197,000 |
| 2017/11/16 | 2,050 | 2,226 | 2,044 | 2,211 | +168 | +8.2% | 995,800 |
| 2017/11/15 | 2,084 | 2,129 | 2,022 | 2,043 | -24 | -1.2% | 416,500 |
| 2017/11/14 | 2,092 | 2,098 | 2,050 | 2,067 | -25 | -1.2% | 209,100 |
| 2017/11/13 | 2,084 | 2,123 | 2,070 | 2,092 | +9 | +0.4% | 194,900 |
| 2017/11/10 | 2,030 | 2,099 | 2,006 | 2,083 | +40 | +2% | 301,900 |
1851～
1900
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
